JPH11209345A - Production of intermediate for drug - Google Patents
Production of intermediate for drugInfo
- Publication number
- JPH11209345A JPH11209345A JP1103598A JP1103598A JPH11209345A JP H11209345 A JPH11209345 A JP H11209345A JP 1103598 A JP1103598 A JP 1103598A JP 1103598 A JP1103598 A JP 1103598A JP H11209345 A JPH11209345 A JP H11209345A
- Authority
- JP
- Japan
- Prior art keywords
- reaction
- formula
- subjected
- same meaning
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Hydrogenated Pyridines (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、医薬品の中間体の製造
方法に関する。さらに詳しくは、式BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for producing a pharmaceutical intermediate. For more information, see the equation
【0002】[0002]
【化20】 Embedded image
【0003】(Rは、4−メトキシベンジル基、3,4
−ジメトキシベンジル基、p−フェニルベンジル基、ト
リフェニルメチル基、p−クロロベンジル基またはベン
ジル基を表わす。)で示される医薬品の中間体の製造方
法に関する。(R is a 4-methoxybenzyl group, 3,4
-Dimethoxybenzyl, p-phenylbenzyl, triphenylmethyl, p-chlorobenzyl or benzyl. )).
【0004】[0004]
【発明の解決しようとする課題】式(Ia)および(I
b)で示される化合物は、一酸化窒素合成酵素阻害剤と
して有用な式(A):The formulas (Ia) and (Ia)
Compounds of formula (b) are useful as nitric oxide synthase inhibitors of formula (A):
【0005】[0005]
【化21】 Embedded image
【0006】(式中、−R1−は、結合位置の炭素原子
と一緒になってピペリジン環のd、eに縮合しているか
または4位にスピロ結合している3または4員炭素環を
表わし、R2は、C1−6アルキルを表わし、R3は、
C1−6アルキル、C2−6アルケニル、C2−6アル
キニルまたはハロゲンを表わし、R4は、水素、アミノ
−C1−4アルキル、アミノ−C1−4アルキルで置換
されていてもよい炭素環−C1−4アルキルを表わし、
iは、0−3を表わし、nは、0−3を表わす。ただ
し、複数のR2またはR3は互いに同じでも異なってい
てもよい。)で示される縮合ピペリジンの合成中間体で
ある(特願平9−273196号参照)。(In the formula, -R1- represents a 3- or 4-membered carbocyclic ring condensed with the carbon atom at the bonding position to d or e of the piperidine ring or spiro-bonded to the 4-position. , R2 represents C1-6 alkyl, and R3 represents
Represents a C1-6 alkyl, a C2-6 alkenyl, a C2-6 alkynyl or a halogen, and R4 represents a hydrogen atom, an amino-C1-4 alkyl, a carbocyclic ring -C1-4 optionally substituted with an amino-C1-4 alkyl. Represents alkyl,
i represents 0-3, and n represents 0-3. However, a plurality of R2 or R3 may be the same or different. )) (See Japanese Patent Application No. 9-273196).
【0007】[0007]
【発明の背景】式(A)で示される化合物は、コンパク
トではあるが、不斉中心を数個有しており、通常の合成
方法では、光学分割が必要となり、コスト、手間が非常
にかかる問題点がある。BACKGROUND OF THE INVENTION The compound represented by the formula (A) is compact, but has several asymmetric centers, and requires optical resolution in a usual synthesis method, which is extremely costly and troublesome. There is a problem.
【0008】[0008]
【従来の技術】式(A)で示される化合物を合成するに
は、いくつかの方法が考えられるが、中間体(Ia)ま
たは(Ib)で示される化合物を用いるとこれ以降の工
程に光学分割が不要になるので、最も簡便であると考え
られる。2. Description of the Related Art There are several methods for synthesizing a compound represented by the formula (A). This is considered to be the simplest because division is not required.
【0009】[0009]
【課題を解決するための手段】本発明者らは、式(I
a)および(Ib)で示される化合物を収率よく、光学
分割を要さない方法で製造すべく検討を重ねた。その結
果、式(II)Means for Solving the Problems The present inventors have made the formula (I)
Investigations were repeated to produce the compounds represented by a) and (Ib) in good yield and without the need for optical resolution. As a result, the formula (II)
【0010】[0010]
【化22】 Embedded image
【0011】で示される化合物を用いることにより、な
んらの光学分割工程を経ることなく、式(Ia)および
(Ib)で示される化合物を作り分ける方法を見いだ
し、本発明を完成した。By using the compound represented by the formula (1), the present inventors have found a method for producing the compounds represented by the formulas (Ia) and (Ib) without going through any optical resolution step, and completed the present invention.
【0012】[0012]
【発明の構成】本発明は、先にも述べたように、光学分
割を経ることなく、式(Ia)および(Ib)を製造す
る方法に関する。本発明を詳述するために、以下の反応
工程式(A)を示す。The present invention relates to a method for producing Formulas (Ia) and (Ib) without optical resolution, as described above. In order to explain the present invention in detail, the following reaction scheme (A) is shown.
【0013】[0013]
【化23】 Embedded image
【0014】本発明の各工程を以下に詳述する。工程
(a)は、還元反応であり、例えば、不活性有機溶媒
(THF、ジエチルエーテル、ジオキサン、ジメトキシ
エタン、ジグライム、塩化メチレン等)中、還元剤(ボ
ラン−ジメチルスルフィド錯体、ボラン−テトラヒドロ
フラン錯体、ジボラン、ボラン−ピリジン錯体、ボラン
−ジメチルアミン錯体等)を用いて、−10〜40℃で
行なわれる。Each step of the present invention will be described in detail below. Step (a) is a reduction reaction, for example, in an inert organic solvent (THF, diethyl ether, dioxane, dimethoxyethane, diglyme, methylene chloride, etc.), a reducing agent (borane-dimethylsulfide complex, borane-tetrahydrofuran complex, Diborane, borane-pyridine complex, borane-dimethylamine complex, etc.) at -10 to 40 ° C.
【0015】工程(b)および(f)は、アミド化反応
であり、例えば、不活性有機溶媒(ベンゼン、トルエ
ン、キシレン、クロルベンゼン、1,2−ジクロロエタ
ン、THF等)中、三級アミン(ジメチルアミノピリジ
ン、トリエチルアミン、ジメチルアニリン、ピリジン
等)の存在下または非存在下、R基に相当する化合物の
アミン(4−メトキシベンジルアミン、3,4−ジメト
キシベンジルアミン、p−フェニルベンジルアミン、ト
リフェニルメチルアミン、p−クロロベンジルアミンま
たはベンジルアミン)を用いて、加熱還流することによ
り行なわれる。Steps (b) and (f) are an amidation reaction, for example, in an inert organic solvent (benzene, toluene, xylene, chlorobenzene, 1,2-dichloroethane, THF, etc.) and a tertiary amine ( In the presence or absence of dimethylaminopyridine, triethylamine, dimethylaniline, pyridine and the like, the amine (4-methoxybenzylamine, 3,4-dimethoxybenzylamine, p-phenylbenzylamine, Phenylmethylamine, p-chlorobenzylamine or benzylamine) and heating to reflux.
【0016】工程(c)および(g)は、酸化および閉
環反応であり、例えば、不活性有機溶媒(1,2−ジク
ロロエタン、塩化メチレン等)中でまたは無溶媒で、三
級アミン(トリエチルアミン、ジイソプロピルエチルア
ミン等)の存在下または非存在下、活性化剤(サルファ
ートリオキシド−ピリジン錯体、DCC等)の存在下ま
たは非存在下、酸化剤(ジメチルスルフォキシド等)を
用いて、0〜50℃で行なわれる。Steps (c) and (g) are oxidation and ring closure reactions, for example, in an inert organic solvent (1,2-dichloroethane, methylene chloride, etc.) or without solvent, with a tertiary amine (triethylamine, Using an oxidizing agent (such as dimethyl sulfoxide) in the presence or absence of an activating agent (such as sulfur trioxide-pyridine complex or DCC) in the presence or absence of diisopropylethylamine or the like; Performed at ° C.
【0017】工程(d)および(h)は、脱水反応であ
り、例えば、不活性有機溶媒(ベンゼン、トルエン、キ
シレン、クロルベンゼン、1,2−ジクロロエタン、T
HF等)中、酸(p−トルエンスルホン酸、メタンスル
ホン酸、硫酸等)を用いて、80〜120℃で行なわれ
る。工程(e)は、1)アルカリ金属塩への変換、2)
還元反応、および3)ラクトン化による閉環反応であ
り、例えば、1)水と混和しうる不活性有機溶媒(メタ
ノール、エタノール、プロパノール、THF、ジオキサ
ン等)を用いるかまたは用いないで、アルカリ(水酸化
リチウム、水酸化ナトリウム、水酸化カリウム、水酸化
バリウム等)の水溶液を用いて、0〜50℃で行なわれ
た後、2)不活性有機溶媒(THF、ジエチルエーテ
ル、ジオキサン、ジメトキシエタン等)中、還元剤(水
素化ホウ素リチウム等)を用いて、0〜70℃で行なわ
れた後、3)不活性有機溶媒(ベンゼン、トルエン、キ
シレン、クロルベンゼン、1,2−ジクロロエタン、T
HF等)中、酸(p−トルエンスルホン酸、メタンスル
ホン酸、硫酸等)を用いて、80〜120℃で行なわれ
る。Steps (d) and (h) are dehydration reactions, for example, using an inert organic solvent (benzene, toluene, xylene, chlorobenzene, 1,2-dichloroethane, T
HF) at 80 to 120 ° C. using an acid (p-toluenesulfonic acid, methanesulfonic acid, sulfuric acid, etc.). Step (e) comprises 1) conversion to an alkali metal salt, 2)
A reduction reaction and 3) a ring closure reaction by lactonization. For example, 1) an alkali (water) with or without an inert organic solvent (methanol, ethanol, propanol, THF, dioxane, etc.) miscible with water. After performing at 0 to 50 ° C. using an aqueous solution of lithium oxide, sodium hydroxide, potassium hydroxide, barium hydroxide, etc., 2) inert organic solvent (THF, diethyl ether, dioxane, dimethoxyethane, etc.) Medium, using a reducing agent (lithium borohydride, etc.) at 0-70 ° C., 3) inert organic solvent (benzene, toluene, xylene, chlorobenzene, 1,2-dichloroethane, T
HF) at 80 to 120 ° C. using an acid (p-toluenesulfonic acid, methanesulfonic acid, sulfuric acid, etc.).
【0018】各工程は、不活性ガス雰囲気下、行なうこ
とが好ましい。また、工程(d)および(h)以外の工
程は、無水状態で行なうことが好ましい。式(II)で
示される化合物は、市販されているが、以下に示す反応
工程式(B)に従っても製造することができる。Each step is preferably performed in an inert gas atmosphere. Further, the steps other than the steps (d) and (h) are preferably performed in an anhydrous state. The compound represented by the formula (II) is commercially available, but can also be produced according to the following reaction step formula (B).
【0019】[0019]
【化24】 Embedded image
【0020】各反応工程式中、出発物質として用いられ
た化合物はそれぞれ公知化合物であるか、あるいは公知
化合物から公知の方法により容易に製造することができ
る。本発明におけるその他の出発物質および各試薬は、
それ自体公知であるか、または公知の方法により製造す
ることができる。本明細書中の各反応において、反応生
成物は通常の精製手段、例えば、常圧下または減圧下に
おける蒸留、シリカゲルまたはケイ酸マグネシウムを用
いた高速液体クロマトグラフィー、薄層クロマトグラフ
ィー、あるいはカラムクロマトグラフィーまたは洗浄、
再結晶等の方法により精製することができる。精製は各
反応毎に行なってもよいし、いくつかの反応終了後に行
なってもよい。In each reaction scheme, the compound used as a starting material is a known compound, or can be easily produced from a known compound by a known method. Other starting materials and each reagent in the present invention are:
They are known per se or can be produced by known methods. In each reaction herein, the reaction product may be purified by conventional purification means, for example, distillation under normal pressure or reduced pressure, high-performance liquid chromatography using silica gel or magnesium silicate, thin-layer chromatography, or column chromatography. Or washing,
It can be purified by a method such as recrystallization. Purification may be performed for each reaction, or may be performed after several reactions are completed.
【0021】[0021]
【参考例および実施例】以下、参考例および実施例によ
って本発明を詳述するが、本発明はこれらに限定される
ものではない。 参考例1 トリメチル 2-メチル-1,1,3-プロパントリカルボキシレ
ート (1)Reference Examples and Examples Hereinafter, the present invention will be described in detail with reference to Reference Examples and Examples, but the present invention is not limited thereto. Reference Example 1 Trimethyl 2-methyl-1,1,3-propanetricarboxylate (1)
【0022】[0022]
【化25】 Embedded image
【0023】アルゴン気流下、100 L反応釜にメタノー
ル37Lを入れ、氷水で冷却(内温〜10℃)して撹拌した
ところへ、内温40 ℃以下を保ち、ナトリウムメトキシ
ド4.2kg (74 mol) を加えた。反応混合物を加熱し、内
温〜40 ℃とした後、マロン酸ジメチル11.5 kg (87 mo
l) とクロトン酸メチル7.4 kg (74 mol) の混合物を 40
分間かけて滴下した。滴下終了後、1〜2時間還流した。
反応混合物を氷水で冷却し、内温約 30 ℃以下で酢酸約
4.23 Lを加え中和した。生じた酢酸ナトリウムを水約4.
9 Lを加えて溶解させた。減圧下でメタノールを留去
し、残渣に氷水約24.5 L、酢酸エチル約 15 Lを加えて
約5分間撹拌した。分液後、水層を酢酸エチル約 10 L
で抽出し、有機層を合わせて水洗(約 8 L X 1)。飽和
食塩水洗(約 16 L X 1)。減圧下で濃縮しトリメチル
2-メチル-1,1,3-プロパントリカルボキシレート (1)
を粗精製油状物として約 19.2 kg (100% up)得た。得
られた粗精製油状物 (1) は、精製することなく次の
反応に用いた。 TLC : UV 吸収、発色液による発色ともに検出不可; Mass : (APCI, Pos., 40V) 233 (M+H)+, 201, 169; NMR : (200MHz, CDCl3) δ3.74 (3H, s), 3.74 (3H,
s), 3.68 (3H, s), 3.46 (1H, d, J=7.0Hz), 2.83-
2.67 (1H, m), 2.54 (1H, dd, J=5.0, 15.8Hz), 2.32
(1H, dd, J=8.4, 15.8Hz), 1.06 (3H, d, J=6.8Hz)。 参考例2 ジメチル 3-メチルグルタレート (2)Under a stream of argon, 37 L of methanol was placed in a 100 L reaction vessel, cooled with ice water (internal temperature to 10 ° C.), and stirred. The internal temperature was kept at 40 ° C. or lower, and sodium methoxide 4.2 kg (74 mol ) Was added. After heating the reaction mixture to an internal temperature of 4040 ° C., 11.5 kg of dimethyl malonate (87 mo
l) and 7.4 kg (74 mol) of methyl crotonate
It was added dropwise over a period of minutes. After the completion of the dropwise addition, the mixture was refluxed for 1 to 2 hours.
The reaction mixture is cooled with ice water, and the acetic acid
4.23 L was added and neutralized. The resulting sodium acetate is converted to water about 4.
9 L was added and dissolved. The methanol was distilled off under reduced pressure, and about 24.5 L of ice water and about 15 L of ethyl acetate were added to the residue, followed by stirring for about 5 minutes. After liquid separation, the aqueous layer was ethyl acetate about 10 L
Extract and wash the combined organic layers with water (about 8 LX 1). Wash with saturated saline (about 16 LX 1). Concentrate under reduced pressure and trimethyl
2-methyl-1,1,3-propanetricarboxylate (1)
Was obtained as a crudely purified oily substance in an amount of about 19.2 kg (100% up). The obtained crude oil (1) was used for the next reaction without purification. TLC: UV absorption and color development by color developing solution are undetectable; Mass: (APCI, Pos., 40V) 233 (M + H) +, 201, 169; NMR: (200MHz, CDCl3) δ3.74 (3H, s) , 3.74 (3H,
s), 3.68 (3H, s), 3.46 (1H, d, J = 7.0Hz), 2.83-
2.67 (1H, m), 2.54 (1H, dd, J = 5.0, 15.8Hz), 2.32
(1H, dd, J = 8.4, 15.8Hz), 1.06 (3H, d, J = 6.8Hz). Reference Example 2 Dimethyl 3-methylglutarate (2)
【0024】[0024]
【化26】 Embedded image
【0025】反応釜に2-メチル-1,1,3-プロパントリカ
ルボキシレート (1) 19 kg (74 mol)、水 1.7 L、DMF
56 L、塩化リチウム3.76 kg (89 mol) を仕込み、内温
137 ℃で約 3〜4時間反応し、1H NMR で (1) が 2
% 以下になったのを確認後加熱を止めて内温約 30 ℃
以下まで冷却した。反応混合物を氷水約 110 L 中に撹
拌しながら入れた後、2N HCl 約 22.9 L を内温約 20
℃ 以下を保ちながら加え pH=4〜5 に調整した。n-ヘキ
サン/酢酸エチル( 3/1 )抽出(約 25 L X 4 )、有
機層を合わせて飽和重曹水洗(約 20 L X 1)、水洗
(約 20 L X 1 )、飽和食塩水洗(約 20 L X 1 )。無
水硫酸マグネシウムで乾燥後、濾過し、減圧下で濃縮し
て粗精製油状物 約 11〜12 L を得た。精密蒸留によ
り、ジメチル 3-メチルグルタレート (2) を無色油状
物として7.92 kg (61.4%、クロトン酸メチル基準)得
た。 TLC : UV 吸収、発色液による発色ともに検出不可; Mass : (APCI, Pos., 20V) 175 (M+H)+, 143; NMR : (200MHz, CDCl3) δ 3.65 (6H, s), 2.51-2.14
(5H, m), 1.00 (3H, d, J=6.4Hz)。 参考例3 メチル (R)-3-メチルグルタレート ((+)-3 )In a reaction vessel, 2-methyl-1,1,3-propanetricarboxylate (1) 19 kg (74 mol), water 1.7 L, DMF
56 L, charged with 3.76 kg (89 mol) of lithium chloride,
The reaction was carried out at 137 ° C for about 3 to 4 hours.
% After confirming that the temperature has become below 30%
Cooled down to: After stirring the reaction mixture in about 110 L of ice water, about 22.9 L of 2N HCl was added thereto at an internal temperature of about 20 L.
The pH was adjusted to 4 to 5 while maintaining the temperature at or below ℃. Extracted with n-hexane / ethyl acetate (3/1) (about 25 LX 4), combined organic layers, washed with saturated sodium bicarbonate water (about 20 LX 1), washed with water (about 20 LX 1), and washed with saturated saline (about 20 LX 1). ). After drying over anhydrous magnesium sulfate, the mixture was filtered and concentrated under reduced pressure to obtain about 11 to 12 L of a crude oil. By precision distillation, 7.92 kg (61.4%, based on methyl crotonate) of dimethyl 3-methylglutarate (2) was obtained as a colorless oil. TLC: UV absorption and color development by color developing solution are undetectable; Mass: (APCI, Pos., 20V) 175 (M + H) +, 143; NMR: (200MHz, CDCl3) δ 3.65 (6H, s), 2.51- 2.14
(5H, m), 1.00 (3H, d, J = 6.4Hz). Reference Example 3 Methyl (R) -3-methylglutarate ((+)-3)
【0026】[0026]
【化27】 Embedded image
【0027】200 L ポリ容器に水 50 L を入れ、りん酸
水素二カリウム 871 g (5.0 mol) を溶解させた後、り
ん酸約 93 mL (1.6 mol) を加えて、pH=7 に調整したと
ころへ、撹拌しながらジメチル 3-メチルグルタレート
(2) 7.5 kg (43.1 mol)、ブタ肝臓エステラーゼ (PL
E) 250,000 ユニットを加えた後、炭酸水素ナトリウム
3.62 kg (43.1 mol) の水 50 L 溶液を加えた( pH=7.8
2 )。室温で約 26 時間撹拌し、ガスクロマトグラフィ
ーで反応終了を確認後(化合物 (2) が 0.5%以下)、
反応混合物中に食塩約 30 kg を加えて溶解させ、酢酸
エチル約 10 Lを加えて撹拌した後、界面に生じた PLE
由来の不溶物を濾別した。反応混合物を 300 L 反応釜
に移し、酢酸エチル約 40 L を加え、撹拌しながら 2N
HCl 約19.6 L を少しずつ加えて pH=4 に調整し、約 5
分間撹拌して分液後、水層に酢酸エチル約 25 L を加
え、2N HCl 約 3.6 L を加えて約 5 分間撹拌した。分
液後、有機層を合わせて、飽和食塩水洗(約 10 L X
1)し、無水硫酸マグネシウムで乾燥後、濾過し、減圧
下で濃縮してメチル (R)-3-メチルグルタレート ((+)-
3) を無色油状物として 6.38 kg( 92.4% ) 得た。 TLC : Rf = 0.39 (n-Hexane/AcOEt, 1/1); Mass : (APCI, Neg., 40V) 159 (M-H)+, 127; NMR : (200MHz, CDCl3) δ 10.50-6.50 (1H, br), 3.67
(3H, s), 2.57-2.19 (5H, m), 1.05 (3H, d, J=6.2H
z)。 実施例1 メチル (R)-5-ヒドロキシ-3-メチルペンタノエート
(4)50 L of water was placed in a 200 L plastic container, and 871 g (5.0 mol) of dipotassium hydrogen phosphate was dissolved. Then, about 93 mL (1.6 mol) of phosphoric acid was added to adjust the pH to 7. While stirring, dimethyl 3-methyl glutarate
(2) 7.5 kg (43.1 mol) of porcine liver esterase (PL
E) After adding 250,000 units, add sodium bicarbonate
3.62 kg (43.1 mol) of a 50 L solution of water was added (pH = 7.8
2). After stirring at room temperature for about 26 hours, confirm the completion of the reaction by gas chromatography (compound (2) is 0.5% or less).
About 30 kg of sodium chloride was added to the reaction mixture to dissolve it, and about 10 L of ethyl acetate was added and stirred.
The insoluble matter derived from it was separated by filtration. Transfer the reaction mixture to a 300 L reaction vessel, add about 40 L of ethyl acetate, and stir 2N
Adjust pH to 4 by adding about 19.6 L of HCl little by little, and add about 5
After stirring for minutes and liquid separation, about 25 L of ethyl acetate was added to the aqueous layer, about 3.6 L of 2N HCl was added, and the mixture was stirred for about 5 minutes. After liquid separation, combine the organic layers and wash with saturated saline (about 10 LX
1), dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure to give methyl (R) -3-methylglutarate ((+)-
3) was obtained as a colorless oil (6.38 kg, 92.4%). TLC: Rf = 0.39 (n-Hexane / AcOEt, 1/1); Mass: (APCI, Neg., 40V) 159 (MH) +, 127; NMR: (200MHz, CDCl3) δ 10.50-6.50 (1H, br ), 3.67
(3H, s), 2.57-2.19 (5H, m), 1.05 (3H, d, J = 6.2H
z). Example 1 Methyl (R) -5-hydroxy-3-methylpentanoate
(Four)
【0028】[0028]
【化28】 Embedded image
【0029】窒素気流下で反応釜にメチル (R)-3-メチ
ルグルタレート (3) 2.83 kg (17.7mol) と脱水 THF
17.7 L を入れ、氷水で冷却して撹拌した。内温が 10
℃ 以下になったら、ボランジメチルスルフィド錯体 2.
0M THF 溶液 9.70 L (19.7 mol)を滴下して 15 分間撹
拌した後、氷水浴から水浴(約 20 ℃)に替えて撹拌し
た。次第に内温が上昇したが、35 ℃ 以下を保って撹拌
し、温度上昇が収ってから 25 〜30 ℃ で約 1 時間撹
拌した。TLC で反応終了を確認後、氷水で冷却し、内温
が10 ℃ 以下になったところで水 11.1 L を注意しなが
ら滴下した。滴下終了後、減圧下で THF を留去し、残
渣に水10 L、酢酸エチル 10 L、食塩 4.7 kg を加えて
約 5 分間撹拌して分液した後、水層を酢酸エチル(10
L x 1、6 L x1)で抽出した。有機層を合わせて無水硫
酸マグネシウムで乾燥後、濾過し、減圧下で濃縮してメ
チル (R)-5-ヒドロキシ-3-メチルペンタノエート (4)
を淡黄色油状物として 2.51 kg(97%)得た。次の物性
値を有する標題化合物 (4)は精製することなく次の反
応に用いた。 TLC : Rf = 0.51 (n-Hexane/AcOEt, 1/1); Mass : (APCI, Pos., 20V) 147 (M+H)+, 129, 115; NMR : (200MHz, CDCl3) δ 3.68 (3H, s), 3.68 (2H,
t, J=6.5Hz), 3.20-2.60(1H, br), 2.42-2.06 (3H, m),
1.67-1.47 (2H, m), 0.99 (3H, d, J=6.4Hz)。 実施例2 (R)-N-(4-メトキシベンジル)-5-ヒドロキシ-3-メチルバ
レルアミド (5)Under a nitrogen stream, 2.83 kg (17.7 mol) of methyl (R) -3-methylglutarate (3) and dehydrated THF were added to the reaction vessel.
17.7 L was added, and the mixture was cooled with ice water and stirred. Internal temperature is 10
When the temperature falls below ℃, the borane dimethyl sulfide complex 2.
9.70 L (19.7 mol) of a 0M THF solution was added dropwise, and the mixture was stirred for 15 minutes. Then, the ice water bath was changed to a water bath (about 20 ° C.) and stirred. Although the internal temperature gradually increased, the mixture was stirred while maintaining the temperature at 35 ° C or lower, and then stirred at 25 to 30 ° C for about 1 hour after the temperature rose. After confirming the completion of the reaction by TLC, the mixture was cooled with ice water, and when the internal temperature became 10 ° C. or lower, 11.1 L of water was carefully added dropwise. After completion of the dropwise addition, THF was distilled off under reduced pressure. To the residue were added 10 L of water, 10 L of ethyl acetate, and 4.7 kg of sodium chloride, and the mixture was stirred for about 5 minutes to separate the layers.
L x 1, 6 L x 1). The organic layers were combined, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure to give methyl (R) -5-hydroxy-3-methylpentanoate (4)
2.51 kg (97%) as a pale yellow oil. The title compound (4) having the following physical data was used for the next reaction without purification. TLC: Rf = 0.51 (n-Hexane / AcOEt, 1/1); Mass: (APCI, Pos., 20V) 147 (M + H) +, 129, 115; NMR: (200MHz, CDCl3) δ 3.68 (3H , s), 3.68 (2H,
t, J = 6.5Hz), 3.20-2.60 (1H, br), 2.42-2.06 (3H, m),
1.67-1.47 (2H, m), 0.99 (3H, d, J = 6.4Hz). Example 2 (R) -N- (4-methoxybenzyl) -5-hydroxy-3-methylvaleramide (5)
【0030】[0030]
【化29】 Embedded image
【0031】反応釜にメチル (R)-5-ヒドロキシ-3-メチ
ルペンタノアート(4) 1780 g (12.2mol)、トルエン 2
5 L を仕込み、撹拌しながら4-メトキシベンジルアミン
1800mL (13.9 mol) を加えた後、反応混合物を加熱
し、1.5 時間還流した(還流開始時の内温は約 110
℃、1.5 時間後約 105 ℃)。反応混合物から低沸点留
分を含むトルエン約 12.5 L を留去してさらに約 1.5
時間還流し、4-メトキシベンジルアミン 125 mL (1.9 m
ol) を追加し、さらに約 1 時間還流した。反応の終了
を TLC で確認後、減圧下でトルエンを留去し、残渣を
酢酸エチル 25 L で希釈後、1N-塩酸 ( 5 L x 2 回 )
、飽和食塩水 ( 4 L ) で洗浄し、洗液を合わせて酢酸
エチル ( 4 L x 3 回 ) で抽出した。有機層を合わせて
無水硫酸マグネシウムで乾燥後、濾過し、減圧下で濃縮
して(R)-N-(4-メトキシベンジル)-5-ヒドロキシ-3-メチ
ルバレルアミド (5) を淡黄色ろう状固体として 3.11
kg (100% up)得た。次の物性値を有する標題化合物
(5) は精製することなく次の反応に用いた。 TLC : Rf = 0.40 (n-Hexane/AcOEt, 1/1); Mass : (APCI, Pos., 40V) 252 (M+H)+, 136, 121; NMR : (200MHz, CDCl3) δ 7.24-7.14 (2H, m), 6.90-
6.81 (2H, m), 6.03 (1H,br), 4.36 (2H, d, J=5.6Hz),
3.79 (3H, s), 3.72-3.59 (2H, m), 2.99 (1H,br), 2.
29-2.01 (3H, m), 1.59-1.46 (2H, m), 0.97 (3H, d, J
=6.6Hz)。 実施例3 (R)-N-(4-メトキシベンジル)-6-ヒドロキシ-3-メチルピ
ペリドン (6)In a reaction vessel, 1780 g (12.2 mol) of methyl (R) -5-hydroxy-3-methylpentanoate (4), toluene 2
Charge 5 L and add 4-methoxybenzylamine with stirring.
After the addition of 1800 mL (13.9 mol), the reaction mixture was heated and refluxed for 1.5 hours (the internal temperature at the start of reflux was about 110
℃, about 105 ℃ after 1.5 hours). About 12.5 L of toluene containing a low-boiling fraction was distilled off from the reaction mixture, and about 1.5
Reflux for 4 hours, and 125 mL of 4-methoxybenzylamine (1.9 m
ol) and refluxed for about another hour. After confirming the completion of the reaction by TLC, toluene was distilled off under reduced pressure.The residue was diluted with 25 L of ethyl acetate, and 1N hydrochloric acid (5 L x 2)
Then, the mixture was washed with saturated saline (4 L), and the combined washings were extracted with ethyl acetate (4 L × 3 times). The organic layers were combined, dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure to give (R) -N- (4-methoxybenzyl) -5-hydroxy-3-methylvaleramide (5) as a pale yellow wax. 3.11 as a solid
kg (100% up). Title compound having the following physical data
(5) was used for the next reaction without purification. TLC: Rf = 0.40 (n-Hexane / AcOEt, 1/1); Mass: (APCI, Pos., 40V) 252 (M + H) +, 136, 121; NMR: (200MHz, CDCl3) δ 7.24-7.14 (2H, m), 6.90-
6.81 (2H, m), 6.03 (1H, br), 4.36 (2H, d, J = 5.6Hz),
3.79 (3H, s), 3.72-3.59 (2H, m), 2.99 (1H, br), 2.
29-2.01 (3H, m), 1.59-1.46 (2H, m), 0.97 (3H, d, J
= 6.6Hz). Example 3 (R) -N- (4-methoxybenzyl) -6-hydroxy-3-methylpiperidone (6)
【0032】[0032]
【化30】 Embedded image
【0033】(R)-N-(4-メトキシベンジル)-5-ヒドロキ
シ-3-メチルバレルアミド (5) 20g (80.0 mmol)のジ
メチルスルホキシド 160mL溶液に、撹拌しながらトリエ
チルアミン 44mL (320 mmol)を加えた後、冷水浴で冷却
し、内温が 20 ℃ 以下になったら、サルファートリオ
キシド−ピリジン錯体 25g (36.6 mol) のジメチルスル
ホキシド 20 mL 懸濁液を内温が 30 ℃ 以下を保つよう
にゆっくり加えた。サルファートリオキシド−ピリジン
錯体懸濁液の添加後、15 〜 20 ℃で 30 分間撹拌す
る。TLC で反応終了を確認後、反応混合物を氷水 950 m
L 中に注ぎ、食塩 50gと酢酸エチル 400 mL を加えて約
3 分間撹拌した。分液後、水層を酢酸エチル(200 mL
x 3 ) で抽出した。有機層を 2N-塩酸 (150mL)、飽和食
塩水 150 mL 、飽和重曹水 150 mL、飽和食塩水 150 mL
で順次洗浄し、無水硫酸マグネシウム約 7 g で乾燥し
た。ついで、シリカゲル(Merck 7734)5 g を加えて約
5 分間撹拌後、濾過し、減圧下で濃縮(アスピレータ
ー、バス温約 40 ℃)した。固体で得られた濃縮物にn-
ヘキサン/酢酸エチル=2/1の混合溶媒を 70 mL 加
え、約 10 分間攪拌して結晶を洗浄した後、結晶を吸引
濾過により濾取し、n-ヘキサン/酢酸エチル=5/1の
混合溶媒 50 mL で結晶を洗浄した。得られた結晶を減
圧乾燥(ポンプ、加温なし)して次の物性値を有する標
題化合物 (6)11.3 g( 57.3% ) を得た。 形状:白色粉末; TLC : Rf = 0.64 (AcOEt); Mass : (APCI, Pos., 20V) 250 (M+H)+; NMR : (200MHz, CDCl3) δ 7.26-7.18 (2H, m), 6.89-
6.80 (2H, m), 5.02-4.90(2H, m), 4.32 (1H, d, J=14.
6Hz), 3.79 (3H, s), 2.71-2.54 (2H, m), 2.44-2.20
(1H, m), 2.09-1.86 (2H, m), 1.47 (1H, ddd, J=3.6,
12.8, 13.6Hz), 1.01 (3H, d, J=6.6Hz); 比旋光度[α]D : +118.1 (c=0.97, MeOH)。 実施例4 (-)-N-(4-メトキシベンジル)-5,6-デヒドロ-3-メチルピ
ペリドン ((-)-7)To a solution of 20 g (80.0 mmol) of (R) -N- (4-methoxybenzyl) -5-hydroxy-3-methylvaleramide (5) in 160 mL of dimethyl sulfoxide was added 44 mL (320 mmol) of triethylamine with stirring. After the addition, the mixture is cooled in a cold water bath, and when the internal temperature becomes 20 ° C or lower, a suspension of 25 g (36.6 mol) of sulfur trioxide-pyridine complex in 20 mL of dimethyl sulfoxide is maintained at 30 ° C or lower. Added slowly. After the addition of the sulfur trioxide-pyridine complex suspension, the mixture is stirred at 15 to 20 ° C for 30 minutes. After confirming the completion of the reaction by TLC, the reaction mixture was ice-water 950 m
And add 50 g of salt and 400 mL of ethyl acetate to add
Stir for 3 minutes. After separation, the aqueous layer was washed with ethyl acetate (200 mL
x 3). The organic layer was washed with 2N-hydrochloric acid (150 mL), saturated saline 150 mL, saturated aqueous sodium bicarbonate 150 mL, saturated saline 150 mL
And dried over about 7 g of anhydrous magnesium sulfate. Then, add 5 g of silica gel (Merck 7734) and add
After stirring for 5 minutes, the mixture was filtered and concentrated under reduced pressure (aspirator, bath temperature: about 40 ° C.). The concentrate obtained as a solid is n-
After adding 70 mL of a mixed solvent of hexane / ethyl acetate = 2/1 and stirring for about 10 minutes to wash the crystals, the crystals are collected by suction filtration and mixed with a mixed solvent of n-hexane / ethyl acetate = 5/1. The crystals were washed with 50 mL. The obtained crystals were dried under reduced pressure (pump, no heating) to give 11.3 g (57.3%) of the title compound (6) having the following physical data. Shape: white powder; TLC: Rf = 0.64 (AcOEt); Mass: (APCI, Pos., 20V) 250 (M + H) +; NMR: (200MHz, CDCl3) δ 7.26-7.18 (2H, m), 6.89 -
6.80 (2H, m), 5.02-4.90 (2H, m), 4.32 (1H, d, J = 14.
6Hz), 3.79 (3H, s), 2.71-2.54 (2H, m), 2.44-2.20
(1H, m), 2.09-1.86 (2H, m), 1.47 (1H, ddd, J = 3.6,
12.8, 13.6 Hz), 1.01 (3H, d, J = 6.6 Hz); specific rotation [α] D: +118.1 (c = 0.97, MeOH). Example 4 (-)-N- (4-methoxybenzyl) -5,6-dehydro-3-methylpiperidone ((-)-7)
【0034】[0034]
【化31】 Embedded image
【0035】反応釜に(R)-N-(4-メトキシベンジル)-6-
ヒドロキシ-3-メチルピペリドン (6)1071 g (4.3 mo
l) とトルエン 24 L を仕込み、撹拌しながらp-トルエ
ンスルホン酸一水和物 24.5 g ( 0.13 mol) を加えた
後、加熱して反応系内に生成する水をトルエンとの共沸
により約 30 分間留去を続けた後、水で冷却した 。反
応の終了を TLC で確認後、反応混合物中にピリジン 1
2.6 mL (0.16 mol) を加え、減圧下でトルエンを留去
し、濃縮物をトルエン約 2 L で洗浄した。無水硫酸マ
グネシウム 30 g を加えて乾燥した後、濾過し、減圧下
で濃縮した。残渣をシリカゲルカラムクロマトグラフィ
ー(シリカゲル( BW-235):15 kg、溶出溶媒:トルエ
ン/酢酸エチル=7/1、240 L ) により精製し、次の物
性値を有する標題化合物 ((-)-7) を無色油状物とし
て919.7 g ( 92.5%, 約 4%wt のトルエンを含む) 得
た。 TLC : Rf = 0.59 (n-Hexane/AcOEt, 1/2); Mass : (APCI, Pos., 40V) 232 (M+H)+, 124, 121; NMR : (200MHz, CDCl3) δ 7.23-7.13 (2H, m), 6.90-
6.81 (2H, m), 5.96 (1H,dd, J=1.6, 7.8Hz), 5.03 (1
H, ddd, J=1.0, 4.0,7.6Hz), 4.61 (2H, dd, J=15.0, 1
7.2Hz), 3.79 (3H, s), 2.70-2.48 (2H, m), 2.38-2.22
(1H, m), 1.05 (3H, d, J=6.8Hz); 比旋光度 [α]D : -88.6 (c=0.89, MeOH)。 実施例5 (R)−4−メチルテトラヒドロ−2H−ピラン−2−オン
(8)(R) -N- (4-methoxybenzyl) -6-
Hydroxy-3-methylpiperidone (6) 1071 g (4.3 mo
l) and 24 L of toluene, 24.5 g (0.13 mol) of p-toluenesulfonic acid monohydrate was added with stirring, and the water generated in the reaction system was heated by azeotropic distillation with toluene. After the distillation was continued for 30 minutes, the mixture was cooled with water. After confirming the completion of the reaction by TLC, pyridine 1 was added to the reaction mixture.
2.6 mL (0.16 mol) was added, toluene was distilled off under reduced pressure, and the concentrate was washed with about 2 L of toluene. After adding and drying 30 g of anhydrous magnesium sulfate, the mixture was filtered and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (silica gel (BW-235): 15 kg, elution solvent: toluene / ethyl acetate = 7/1, 240 L) to give the title compound ((-)-7 having the following physical data). ) As a colorless oil (919.7 g, containing 92.5%, about 4% wt toluene). TLC: Rf = 0.59 (n-Hexane / AcOEt, 1/2); Mass: (APCI, Pos., 40V) 232 (M + H) +, 124, 121; NMR: (200MHz, CDCl3) δ 7.23-7.13 (2H, m), 6.90-
6.81 (2H, m), 5.96 (1H, dd, J = 1.6, 7.8Hz), 5.03 (1
H, ddd, J = 1.0, 4.0,7.6Hz), 4.61 (2H, dd, J = 15.0, 1
7.2Hz), 3.79 (3H, s), 2.70-2.48 (2H, m), 2.38-2.22
(1H, m), 1.05 (3H, d, J = 6.8 Hz); specific rotation [α] D: -88.6 (c = 0.89, MeOH). Example 5 (R) -4-methyltetrahydro-2H-pyran-2-one
(8)
【0036】[0036]
【化32】 Embedded image
【0037】メチル (R)−3−メチルグルタレート
((+)-3) (36 g, 224.8 mmoL) に、0.2mol/L の水酸化
リチウム水溶液を加えて、室温下で10分間撹拌した。次
いて、混合液を濃縮し、トルエン (150 mL×3) を加え
て、共沸させた後、減圧下乾燥させて、白色結晶を得
た。続いて、アルゴン雰囲気下、得られた白色結晶に T
HF(300 mL) を加えて、水素化ホウ素リチウム (10.8 g,
495.9 mmoL) と THF (100 mL) の懸濁液を約1時間かけ
て滴下した。滴下終了後、50℃にて3時間撹拌した。反
応終了後、メタノール (70 mL) をゆっくり加えて、50
℃にて30分間撹拌した。反応液を濃縮後、水 (200 mL)
を加え、6N塩酸 (150 mL) を加えて、pH = 2にし、酢酸
エチル (200 mL×6) で抽出した。有機層に無水硫酸マ
グネシウムを加えて乾燥し、濃縮した後、p-トルエンス
ルホン酸一水和物 (430 mg) 、ベンゼン (150 mL) を加
えて濃縮して、粗生成物として 40 g を得た。一部デー
タを取るために、シリカゲルカラム精製を行い、次の物
性値を有する標題化合物(8)を得た。 TLC : Rf 0.49 (n−ヘキサン : 酢酸エチル = 1 : 1); NMR: (CDCl3, 200MHz) δ 4.48-4.38 (1H, m), 4.33-4.
20 (1H, m), 2.85-2.60(1H, m), 2.20-1.85 (2H, m),
1.65-1.46 (1H, m), 1.07 (3H, d, J=6.6 Hz);MS: (APC
I, Pos.20V) 115 (M)+。 実施例6 (S)−N−(4−メトキシベンジル)−5−ヒドロキシ−3
−メチルバレルアミド(9)Methyl (R) -3-methylglutarate
((+)-3) A 0.2 mol / L aqueous solution of lithium hydroxide was added to (36 g, 224.8 mmoL), and the mixture was stirred at room temperature for 10 minutes. Subsequently, the mixture was concentrated, toluene (150 mL × 3) was added thereto, and the mixture was azeotropically dried, and dried under reduced pressure to obtain white crystals. Then, under argon atmosphere, T
HF (300 mL) was added and lithium borohydride (10.8 g,
A suspension of 495.9 mmoL) and THF (100 mL) was added dropwise over about 1 hour. After completion of the dropwise addition, the mixture was stirred at 50 ° C. for 3 hours. After the reaction is completed, slowly add methanol (70 mL) and add 50 mL
Stirred at 30 ° C. for 30 minutes. After concentrating the reaction solution, water (200 mL)
Was added, and 6N hydrochloric acid (150 mL) was added to adjust the pH to 2, followed by extraction with ethyl acetate (200 mL × 6). The organic layer was dried over anhydrous magnesium sulfate, concentrated, and then concentrated by adding p-toluenesulfonic acid monohydrate (430 mg) and benzene (150 mL) to obtain 40 g as a crude product. Was. Purification by silica gel column was performed to obtain some data, and the title compound (8) having the following physical data was obtained. TLC: Rf 0.49 (n-hexane: ethyl acetate = 1: 1); NMR: (CDCl3, 200MHz) δ 4.48-4.38 (1H, m), 4.33-4.
20 (1H, m), 2.85-2.60 (1H, m), 2.20-1.85 (2H, m),
1.65-1.46 (1H, m), 1.07 (3H, d, J = 6.6 Hz); MS: (APC
I, Pos. 20V) 115 (M) +. Example 6 (S) -N- (4-methoxybenzyl) -5-hydroxy-3
-Methylvaleramide (9)
【0038】[0038]
【化33】 Embedded image
【0039】アルゴン雰囲気下、(R)−4−メチルテト
ラヒドロ−2H−ピラン−2−オン (8) (40 g, 224.8
mmoL)、トルエン (418 mL)、p-メトキシベンジルアミン
(35 mL, 269.7 mmoL)の混合物を、1時間加熱還流し
た。反応終了後、セライトろ過し、濃縮した。得られた
残留物に2N塩酸 (200 mL) を加えて、酢酸エチル (300
mL×5) で抽出した。得られた有機層に無水硫酸マグネ
シウムを加えて乾燥し、次いで濃縮し、次の物性値を有
する標題化合物 (9) (54 g) を得た。 TLC: Rf 0.28 (酢酸エチル); NMR: (CDCl3, 200MHz) δ 7.21 (2H, d, J=8.8 Hz), 6.
87 (2H, d, J=8.8 Hz),5.84 (1H, brs), 4.38 (2H, d,
J=5.6 Hz) 3.80 (3H, s), 3.70-3.60 (2H, m),2.30-2.0
5 (3H, m), 1.60-1.50 (2H, m), 0.99 (3H, d, J=6.6 H
z); MS: (APCI, Pos.20V) 121, 252 (M)+。 実施例7 (S)−N−(4−メトキシベンジル)−6−ヒドロキシ−3
−メチルピペリドン (10)Under an argon atmosphere, (R) -4-methyltetrahydro-2H-pyran-2-one (8) (40 g, 224.8
mmoL), toluene (418 mL), p-methoxybenzylamine
(35 mL, 269.7 mmoL) was heated to reflux for 1 hour. After completion of the reaction, the mixture was filtered through celite and concentrated. 2N hydrochloric acid (200 mL) was added to the obtained residue, and ethyl acetate (300 mL) was added.
mL × 5). The obtained organic layer was dried over anhydrous magnesium sulfate, and concentrated to give the title compound (9) (54 g) having the following physical data. TLC: Rf 0.28 (ethyl acetate); NMR: (CDCl3, 200MHz) δ 7.21 (2H, d, J = 8.8 Hz), 6.
87 (2H, d, J = 8.8 Hz), 5.84 (1H, brs), 4.38 (2H, d,
J = 5.6 Hz) 3.80 (3H, s), 3.70-3.60 (2H, m), 2.30-2.0
5 (3H, m), 1.60-1.50 (2H, m), 0.99 (3H, d, J = 6.6 H
z); MS: (APCI, Pos. 20V) 121, 252 (M) +. Example 7 (S) -N- (4-methoxybenzyl) -6-hydroxy-3
-Methylpiperidone (10)
【0040】[0040]
【化34】 Embedded image
【0041】(S)−N−(4−メトキシベンジル)−5−ヒ
ドロキシ−3−メチルバレルアミド(9) (53.9 g, 21
4.36 mmoL) にジメチルスルホキシド (431 mL)、トリエ
チルアミン (149 mL, 1072 mmoL) を加えて、15℃に冷
却し、ピリジン−サルファートリオキシド錯体 (85.3
g, 535.9 mmoL) のジメチルスルホキシド (60 mL) 懸濁
液をゆっくり加えて、15℃にて30分間撹拌した。反応終
了後、反応液を氷水 (2L) にあけて、酢酸エチル (300
mL×5) で抽出した。有機層を2N-塩酸 (200 mL)、飽和
食塩水 (200 mL)、飽和重曹水 (200 mL)、飽和食塩水
(200 mL) で順次洗浄した後、無水硫酸マグネシウムを
加えて乾燥し、濃縮すると白色結晶が析出した。得られ
た結晶にn-ヘキサン/酢酸エチル=2/1の混合溶媒を1
50 mL 加え、約10分間撹拌して結晶を洗浄した後、吸引
濾過により濾取し、 n-ヘキサン/酢酸エチル=5/1の
混合溶媒で結晶を洗浄した。得られた結晶を減圧乾燥し
て、次の物性値を有する標題化合物 (10) (23 g) を
得た。 TLC : Rf 0.45 (酢酸エチル); NMR :(CDCl3, 200MHz) δ 7.23 (2H, d, J=8.8 Hz), 6.
85 (2H, d, J=8.8 Hz),4.95 (1H, d, J=14.2 Hz), 5.00
-4.88 (1H, m), 4.34 (1H, d, J=14.2 Hz), 3.79 (3H,
s), 2.70-2.52 (1H, m), 2.40-2.18 (1H, brs), 2.10-
1.80 (2H, m), 1.65-1.36 (2H, m), 1.00 (3H, d, J=6.
6 Hz); MS :(APCI, Pos.20V) 121, 252 (M)+; 比旋光度:[α]D -168.13 (c 0.95, MeOH)。 実施例8 (R)−N−(4−メトキシベンジル)−5、6−デヒドロ−
3−メチルピペリドン ((+)-7)(S) -N- (4-methoxybenzyl) -5-hydroxy-3-methylvaleramide (9) (53.9 g, 21
Dimethylsulfoxide (431 mL) and triethylamine (149 mL, 1072 mmol) were added to the mixture and cooled to 15 ° C.
g, 535.9 mmoL) in dimethylsulfoxide (60 mL) was added slowly, and the mixture was stirred at 15 ° C for 30 minutes. After completion of the reaction, the reaction solution was poured into ice water (2 L), and ethyl acetate (300
mL × 5). The organic layer was washed with 2N hydrochloric acid (200 mL), saturated saline (200 mL), saturated aqueous sodium bicarbonate (200 mL), and saturated saline.
(200 mL), dried over anhydrous magnesium sulfate, and concentrated to precipitate white crystals. A mixed solvent of n-hexane / ethyl acetate = 2/1 was added to the obtained crystals in 1
After adding 50 mL and stirring for about 10 minutes to wash the crystals, the crystals were collected by suction filtration and washed with a mixed solvent of n-hexane / ethyl acetate = 5/1. The obtained crystals were dried under reduced pressure to give the title compound (10) (23 g) having the following physical data. TLC: Rf 0.45 (ethyl acetate); NMR: (CDCl3, 200MHz) δ 7.23 (2H, d, J = 8.8 Hz), 6.
85 (2H, d, J = 8.8 Hz), 4.95 (1H, d, J = 14.2 Hz), 5.00
-4.88 (1H, m), 4.34 (1H, d, J = 14.2 Hz), 3.79 (3H,
s), 2.70-2.52 (1H, m), 2.40-2.18 (1H, brs), 2.10-
1.80 (2H, m), 1.65-1.36 (2H, m), 1.00 (3H, d, J = 6.
MS: (APCI, Pos. 20V) 121, 252 (M) +; Specific rotation: [α] D -168.13 (c 0.95, MeOH). Example 8 (R) -N- (4-methoxybenzyl) -5,6-dehydro-
3-methylpiperidone ((+)-7)
【0042】[0042]
【化35】 Embedded image
【0043】(S)−N−(4−メトキシベンジル)−6−ヒ
ドロキシ−3−メチルピペリドン (10) (11 g, 44.0
mmoL)にトルエン (200 mL)、p-トルエンスルホン酸一水
和物 (130 mg, 0.69 mmoL)を加えて、80℃にて1時間撹
拌した。反応終了後、室温まで冷却した後、濃縮した。
得られた残留物にトルエン (50 mL)、ピリジン (0.06 m
L)加えて濃縮して、シリカゲルカラムクロマトグラフィ
ー (Merck 7734, 110 g,n-ヘキサン/酢酸エチル=5/1)
で精製を行い、次の物性値を有する標題化合物((+)-
7) (10.2 g) を得た。 TLC : Rf 0.58 (n-ヘキサン : 酢酸エチル=1 : 1); NMR (CDCl3, 200MHz) δ 7.17 (2H, d, J=8.8 Hz), 6.8
4 (2H, d, J=8.8 Hz), 5.96 (1H, dd, J=7.7, 1.5 Hz),
5.03 (1H, dd, J=7.7, 3.4 Hz), 4.61 (2H, d,J=2.6 H
z), 3.79 (3H, s), 2.70-2.50 (2H, m), 2.40-2.15 (1
H, m), 1.05 (3H,d, J=6.8 Hz); MS: (APCI, Pos.20V) 124, 232 (M)+; 比旋光度:[α]D +84.53 (c 0.92, MeOH)。(S) -N- (4-methoxybenzyl) -6-hydroxy-3-methylpiperidone (10) (11 g, 44.0
mmoL), toluene (200 mL) and p-toluenesulfonic acid monohydrate (130 mg, 0.69 mmoL) were added, and the mixture was stirred at 80 ° C for 1 hour. After completion of the reaction, the mixture was cooled to room temperature and concentrated.
Toluene (50 mL), pyridine (0.06 m
L) and concentrate, silica gel column chromatography (Merck 7734, 110 g, n-hexane / ethyl acetate = 5/1)
The title compound ((+)-
7) (10.2 g) was obtained. TLC: Rf 0.58 (n-hexane: ethyl acetate = 1: 1); NMR (CDCl3, 200MHz) δ 7.17 (2H, d, J = 8.8 Hz), 6.8
4 (2H, d, J = 8.8 Hz), 5.96 (1H, dd, J = 7.7, 1.5 Hz),
5.03 (1H, dd, J = 7.7, 3.4 Hz), 4.61 (2H, d, J = 2.6 H
z), 3.79 (3H, s), 2.70-2.50 (2H, m), 2.40-2.15 (1
H, m), 1.05 (3H, d, J = 6.8 Hz); MS: (APCI, Pos. 20V) 124, 232 (M) +; Specific rotation: [α] D +84.53 (c 0.92, MeOH) .
Claims (5)
トキシベンジル基、p−フェニルベンジル基、トリフェ
ニルメチル基、p−クロロベンジル基またはベンジル基
を表わす。)で示される化合物をそれぞれ脱水反応に付
すことを特徴とする式 【化2】 (式中、Rは前記と同じ意味を表わす。)で示される化
合物の製造方法。(1) Formula (1) (Wherein, R represents a 4-methoxybenzyl group, a 3,4-dimethoxybenzyl group, a p-phenylbenzyl group, a triphenylmethyl group, a p-chlorobenzyl group or a benzyl group). A formula characterized by subjecting to a dehydration reaction (Wherein, R represents the same meaning as described above).
される化合物をそれぞれ酸化反応および閉環反応に付
し、得られた式 【化4】 (式中、Rは前記と同じ意味を表わす。)で示される化
合物をそれぞれ脱水反応に付すことを特徴とする式 【化5】 (式中、Rは前記と同じ意味を表わす。)で示される化
合物の請求項1記載の製造方法。2. The formula: (Wherein R has the same meaning as described in claim 1). The compound represented by the formula (1) is subjected to an oxidation reaction and a ring-closure reaction, respectively, to obtain the resulting compound. (Wherein R has the same meaning as described above), wherein each of the compounds is subjected to a dehydration reaction. (Wherein, R represents the same meaning as described above).
れた式 【化7】 (式中、Rは請求項1記載と同じ意味を表わす。)で示
される化合物をそれぞれ酸化反応および閉環反応に付
し、得られた式 【化8】 (式中、Rは前記と同じ意味を表わす。)で示される化
合物をそれぞれ脱水反応に付すことを特徴とする式 【化9】 (式中、Rは前記と同じ意味を表わす。)で示される化
合物の請求項1または2記載の製造方法。3. The formula: Are subjected to an amidation reaction to obtain the resulting compound of the formula (Wherein R has the same meaning as described in claim 1). The compound represented by the formula (1) is subjected to an oxidation reaction and a ring-closure reaction, respectively, to obtain the resulting compound. (Wherein R has the same meaning as described above), wherein each of the compounds is subjected to a dehydration reaction. (Wherein R has the same meaning as described above).
式 【化11】 で示される化合物をそれぞれアミド化反応に付し、得ら
れた式 【化12】 (式中、Rは請求項1記載と同じ意味を表わす。)で示
される化合物をそれぞれ酸化反応および閉環反応に付
し、得られた式 【化13】 (式中、Rは前記と同じ意味を表わす。)で示される化
合物をそれぞれ脱水反応に付すことを特徴とする式 【化14】 (式中、Rは前記と同じ意味を表わす。)で示される化
合物の請求項1、2または3記載の製造方法。4. The formula: The compounds of the formulas are each subjected to a reduction reaction and the resulting formula Are subjected to an amidation reaction to obtain the resulting compound of the formula (Wherein R has the same meaning as in claim 1). The compound represented by the formula (1) is subjected to an oxidation reaction and a ring-closure reaction, respectively, to obtain the resulting compound. (Wherein R has the same meaning as described above), wherein each of the compounds is subjected to a dehydration reaction. (Wherein R represents the same meaning as described above).
換反応、2)還元反応および3)ラクトン化反応に付
し、得られた式 【化16】 で示される化合物をそれぞれアミド化反応に付し、得ら
れた式 【化17】 (式中、Rは請求項1記載と同じ意味を表わす。)で示
される化合物をそれぞれ酸化反応および閉環反応に付
し、得られた式 【化18】 (式中、Rは前記と同じ意味を表わす。)で示される化
合物をそれぞれ脱水反応に付すことを特徴とする式 【化19】 (式中、Rは前記と同じ意味を表わす。)で示される化
合物の請求項1、2または3記載の製造方法。5. The formula: Are subjected to 1) a conversion reaction to an alkali metal salt, 2) a reduction reaction, and 3) a lactonization reaction, respectively, to obtain a compound represented by the following formula: Are subjected to an amidation reaction to obtain the resulting compound of the formula (Wherein R has the same meaning as in claim 1). The compound represented by the formula (1) is subjected to an oxidation reaction and a ring-closure reaction, respectively, to obtain the resulting compound. Wherein R represents the same meaning as described above, wherein each of the compounds is subjected to a dehydration reaction. (Wherein R represents the same meaning as described above).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1103598A JPH11209345A (en) | 1998-01-23 | 1998-01-23 | Production of intermediate for drug |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1103598A JPH11209345A (en) | 1998-01-23 | 1998-01-23 | Production of intermediate for drug |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH11209345A true JPH11209345A (en) | 1999-08-03 |
Family
ID=11766819
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1103598A Pending JPH11209345A (en) | 1998-01-23 | 1998-01-23 | Production of intermediate for drug |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH11209345A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008140127A1 (en) * | 2007-05-14 | 2008-11-20 | Sumitomo Chemical Company, Limited | Process for producing optically active 2-alkyl-1,1,3-trialkoxycarbonylpropane |
CN108358783A (en) * | 2018-04-13 | 2018-08-03 | 华烁科技股份有限公司 | The preparation method of 3- substituent glutaric acids diester and glutaconate diester |
-
1998
- 1998-01-23 JP JP1103598A patent/JPH11209345A/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008140127A1 (en) * | 2007-05-14 | 2008-11-20 | Sumitomo Chemical Company, Limited | Process for producing optically active 2-alkyl-1,1,3-trialkoxycarbonylpropane |
JP2009005682A (en) * | 2007-05-14 | 2009-01-15 | Sumitomo Chemical Co Ltd | Process for producing optically active 2-alkyl-1,1,3-trialkoxycarbonylpropane |
US8969051B2 (en) | 2007-05-14 | 2015-03-03 | Sumitomo Chemical Company, Limited | Process for producing optically active 2-alkyl-1,1,3-trialkoxycarbonylpropane |
US9970043B2 (en) | 2007-05-14 | 2018-05-15 | Genentech, Inc. | Process for producing optically active 2-alkyl-1,1,3-trialkoxycarbonylpropane |
CN108358783A (en) * | 2018-04-13 | 2018-08-03 | 华烁科技股份有限公司 | The preparation method of 3- substituent glutaric acids diester and glutaconate diester |
CN108358783B (en) * | 2018-04-13 | 2021-04-06 | 华烁科技股份有限公司 | 3-substituted glutaric diester and preparation method of glutaconic diester |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3528186B2 (en) | Diastereomeric salts of optically active quinoline mevalonic acid | |
JPS63139182A (en) | Production of thiazolidinedione derivative | |
EP3481200B1 (en) | Processes for the preparation of 4-alkoxy-3-(acyl or alkyl)oxypicolinamides | |
JP2010111684A (en) | Stereoselective alkylation of chiral 2-methyl-4-protected piperazine | |
JPH11209345A (en) | Production of intermediate for drug | |
JP6884857B2 (en) | Method for producing phenylalanine compounds | |
JPS6355512B2 (en) | ||
EP2907810A1 (en) | A new method for producing nebivolol hydrochloride of high purity | |
JP3121656B2 (en) | Optically active glycidol derivative and method for producing the same | |
KR100856133B1 (en) | Improved process for preparing atorvastatin | |
JP2001158774A (en) | Method for producing 6-trifluoromethylnicotinic acids | |
JP3272340B2 (en) | Method for producing 1-[(cyclopent-3-en-1-yl) methyl] -5-ethyl-6- (3,5-dimethylbenzoyl) -2,4-pyrimidinedione | |
JP4075357B2 (en) | 4,5-disubstituted-1,2,3-triazole and process for producing the same | |
KR100466797B1 (en) | Benzoazepin derivatives and process for production thereof using indium | |
JPWO2006083010A1 (en) | Method for producing 4-acetylpyrimidine compound and crystal thereof | |
JP4260911B2 (en) | Method for racemization of pyrrolidinone derivatives | |
EP4509510A1 (en) | Synthesis method for 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2,3-f]chromene derivative | |
KR100424393B1 (en) | Process for the preparation of oxiracetam | |
JPH041746B2 (en) | ||
JP2950680B2 (en) | 3-Amino-5-o-chlorobenzyl-4,5,6,7-tetrahydrothieno [3,2-c] pyridine-2-carboxylic acid derivative and method for producing the same | |
JP2001026591A (en) | Azoniaadamantane compound, production of azaadamantane compound from the same and production of the azoniaadamantane compound | |
JPH11302216A (en) | Production of dialkoxy-substituted indanone derivative | |
JPH041736B2 (en) | ||
JPH07291946A (en) | Production of (s)-3-lower alkyl-2-piperazinone | |
JPH08157459A (en) | Production of optically active 5-hydroxymethyl-oxazolidinone derivative |